{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T21:40:54Z","timestamp":1760996454816,"version":"build-2065373602"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Primary cutaneous Epstein\u2013Barr virus (EBV)-positive polymorphic B-cell lymphoproliferative disorder (LPD) is a rare LPD associated with iatrogenic and endogenous immune dysregulation with the commonest risk factor being immunosuppressive therapy. We present a 55-year-old woman with rheumatoid arthritis, previously on methotrexate, who developed a waxing and waning papulonodular eruption on the chest and neck. Histopathology revealed a lymphohistiocytic infiltrate with atypical EBV<jats:sup>+<\/jats:sup>\/CD30<jats:sup>+<\/jats:sup> B cells, consistent with EBV<jats:sup>+<\/jats:sup> polymorphic B-cell LPD. Although discontinuation of methotrexate initially resulted in complete lesional resolution, recurrence occurred 2 years later while the patient was on rituximab therapy. The patient subsequently developed lymphadenopathy, and biopsy confirmed angioimmunoblastic T-cell lymphoma. Notably, earlier skin samples harbored the same T-cell clone found in the lymph node. This case underscores the dynamic evolution of EBV<jats:sup>+<\/jats:sup> polymorphic B-cell LPD, where an initial clonal T-cell response to infected atypical B cells eventuated into angioimmunoblastic T-cell lymphoma.<\/jats:p>","DOI":"10.1097\/dad.0000000000003116","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T17:00:16Z","timestamp":1756918816000},"page":"857-865","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Methotrexate-Associated Primary Cutaneous Epstein\u2013Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder With Metachronous T-Cell Clonally Related Angioimmunoblastic T-Cell Lymphoma: A Case Report and Review of the Literature"],"prefix":"10.1097","volume":"47","author":[{"given":"Tiffany","family":"Liu","sequence":"first","affiliation":[{"name":"Georgetown University School of Medicine, Washington, DC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Brunner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Marushchak","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrisanna","family":"Dobrowolski","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Salib","sequence":"additional","affiliation":[{"name":"Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Magro","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"R1-20251020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"New Engl J Med"},{"key":"R2-20251020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2230.2009.03293.x","article-title":"Methotrexate-induced primary cutaneous diffuse large B-cell lymphoma with an \u201cangiocentric\u201d histological morphology","volume":"35","author":"Pfistershammer","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R3-20251020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R4-20251020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.pathol.2020.10.019","article-title":"Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features","volume":"53","author":"Satou","year":"2021","journal-title":"Pathology"},{"key":"R5-20251020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-Associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"R6-20251020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0190-9622(00)90273-1","article-title":"Cutaneous presentation of posttransplant lymphoproliferative disorder","volume":"42","author":"Schumann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R7-20251020","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/PAS.0000000000000225","article-title":"Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: a clinicopathologic and immunophenotypical study of 10 cases","volume":"38","author":"Koens","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R8-20251020","doi-asserted-by":"crossref","first-page":"105696","DOI":"10.1016\/j.humpath.2024.105696","article-title":"Angioimmunoblastic T-cell lymphoma: current diagnostic insights and advances","volume":"156","author":"Matsumoto","year":"2025","journal-title":"Hum Pathol"},{"key":"R9-20251020","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"R10-20251020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/DAD.0000000000000695","article-title":"Primary cutaneous follicular helper T-Cell lymphoma: a case series and review of the literature","volume":"39","author":"Wang","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"R11-20251020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/modpathol.3800536","article-title":"CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells","volume":"19","author":"Reichard","year":"2006","journal-title":"Mod Pathol"},{"key":"R12-20251020","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3390\/cancers13153815","article-title":"Epstein-Barr virus positive B-Cell lymphoproliferative disorder of the gastrointestinal tract","volume":"13","author":"Ishikawa","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R13-20251020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1399-3062.2001.003002060.x","article-title":"The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis","volume":"3","author":"Tanner","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"R14-20251020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1034\/j.1399-3046.2002.02043.x","article-title":"Epstein-Barr virus and post-transplant lymphoproliferative disease","volume":"6","author":"Holmes","year":"2002","journal-title":"Pediatr Transpl"},{"key":"R15-20251020","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0041-1345(03)00667-5","article-title":"Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients","volume":"35","author":"Soler","year":"2003","journal-title":"Transpl Proc"},{"key":"R16-20251020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1099-1654(199910\/12)9:4<263::AID-RMV256>3.0.CO;2-D","article-title":"In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD)","volume":"9","author":"Johannessen","year":"1999","journal-title":"Rev Med Virol"},{"key":"R17-20251020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2559.2003.01636.x","article-title":"Plasmablastic lymphoma in HIV+ patients: an expanding spectrum","volume":"42","author":"Chetty","year":"2003","journal-title":"Histopathology"},{"key":"R18-20251020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.0303-6987.2005.00258.x","article-title":"Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation","volume":"32","author":"Verma","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R19-20251020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-195102000-00008","article-title":"Therapeutic suppression of tissue reactivity. I. Comparison of the effects of cortisone and aminopterin","volume":"221","author":"Gubner","year":"1951","journal-title":"Am J Med Sci"},{"key":"R20-20251020","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas","volume":"96","author":"Feng","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R21-20251020","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar2708","article-title":"Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies","volume":"11","author":"Miceli-Richard","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R22-20251020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3960\/jslrt.19028","article-title":"Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients","volume":"59","author":"Saito","year":"2019","journal-title":"J Clin Exp Hematop"},{"key":"R23-20251020","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida","year":"2007","journal-title":"J Rheumatol"},{"key":"R24-20251020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/DAD.0000000000002479","article-title":"Epstein-Barr virus-associated lymphomatoid papules: a sign of immunosuppression resembling lymphomatoid papulosis","volume":"45","author":"Hooper","year":"2023","journal-title":"Am J Dermatopathol"},{"key":"R25-20251020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/pin.13424","article-title":"Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves","volume":"74","author":"Tsujii","year":"2024","journal-title":"Pathol Int"},{"key":"R26-20251020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/DAD.0000000000000272","article-title":"Primary cutaneous polymorphic EBV-Associated posttransplant lymphoproliferative disorder after a renal transplant and review of the literature","volume":"37","author":"Ferguson","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R27-20251020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/cup.13427","article-title":"Primary cutaneous Hodgkin-like polymorphic post-transplant lymphoproliferative disorder","volume":"46","author":"Dunn","year":"2019","journal-title":"J Cutan Pathol"},{"key":"R28-20251020","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.joms.2018.12.035","article-title":"Epstein-Barr virus-positive mucocutaneous ulcer mimicking peri-implantitis in a patient with systemic lupus erythematosus","volume":"77","author":"Takahama","year":"2019","journal-title":"J Oral Maxillofac Surg"},{"key":"R29-20251020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/jdv.12958","article-title":"Cutaneous Epstein-Barr virus-associated lymphoproliferative polymorphic disease\u2014AIDS presenting manifestation","volume":"30","author":"Massa","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R30-20251020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1684\/ejd.2015.2582","article-title":"Methotrexate-associated lymphoproliferative disorder: sequential development of angioimmunoblastic T-cell lymphoma-like lymphoproliferation in the lymph nodes and diffuse large B-cell lymphoma in the skin in the same patient","volume":"25","author":"Ishibuchi","year":"2015","journal-title":"Eur J Dermatol"},{"key":"R31-20251020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41379-019-0264-2","article-title":"Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases","volume":"32","author":"Satou","year":"2019","journal-title":"Mod Pathol"},{"key":"R32-20251020","doi-asserted-by":"crossref","first-page":"625442","DOI":"10.3389\/fmed.2020.625442","article-title":"Case report: composite angioimmunoblastic T-Cell lymphoma and Epstein-Barr virus-positive B-Cell lymphoproliferative disorder as other iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"7","author":"Kakiuchi","year":"2020","journal-title":"Front Med (Lausanne)"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T21:00:14Z","timestamp":1760994014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003116","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"type":"print","value":"0193-1091"},{"type":"electronic","value":"1533-0311"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}